Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05598164
Other study ID # 56IG701SSCC979
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date September 1, 2022
Est. completion date May 1, 2025

Study information

Verified date September 2022
Source State Scientific Centre of Coloproctology, Russian Federation
Contact Evgeny E. Zharkov, MD
Phone +79039689739
Email drzharkov@mail.ru
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study is aimed at studying the effectiveness and safety of surgical treatment of chronic anal fissure.


Description:

A chronic anal fissure is a rupture of the mucous membrane of the anal canal, lasting more than 2 months and resistant to non-surgical treatment. This condition is accompanied by a strong pain syndrome during and after defecation (defecation). This condition is most often found in young and able-bodied adults, so the issue of treatment is of particular relevance. The main cause of the development of a chronic anal fissure is a spasm of the internal sphincter. It should be eliminated first of all to ensure effective therapy. All the main treatment methods, such as medicinal relaxation of the internal sphincter with 0.4% nitroglycerin ointment, lateral subcutaneous sphincterotomy, and pneumodivulsion of the anal sphincter are aimed at its removal. However, the optimal method has not yet been developed. Non-surgical treatments are often attended by relapse of disease, while surgical treatment is often complicated by intestinal contents incontinence, usually gas and loose or hard stool in some occasions (grade 3 anal sphincter insufficiency). In particular, lateral subcutaneous sphincterotomy performed in such patients is associated with an increase in the degree of anal incontinence in the early post-operative period. Botulinum Toxin Type A application in treatment of patients with chronic anal fissure (after fissure excision) is intended to improve the therapy results, namely to reduce the frequency and duration of anal sphincter insufficiency after sphincter spasm removal (reduction in the number of patients suffering from post-operative incontinence).


Recruitment information / eligibility

Status Recruiting
Enrollment 140
Est. completion date May 1, 2025
Est. primary completion date May 1, 2023
Accepts healthy volunteers No
Gender All
Age group 18 Years to 70 Years
Eligibility Inclusion Criteria: - Patients with chronic anal fissure with spasm of anal sphincter Exclusion Criteria: - Inflammatory diseases of the colon - Pectenosis - Previous surgical interventions on the anal canal - IV grade internal and external hemorrhoids - Rectal fistula - Severe somatic diseases at the decompensation stage - Pregnancy and lactation - Anal sphincter insufficiency - Chronic paraproctitis - Fibrous polyp of the anal canal, accompanied by clinical manifestations - Individual intolerance and hypersensitivity to botulinum toxin - Myasthenia gravis and myasthenic syndromes

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Botulinum toxin type A
Patients of main group are treated with injection in internal sphincter botulinum toxin type A. In the control group, the fissure is excised in combination with a injection in internal sphincter botulinum toxin type A.

Locations

Country Name City State
Russian Federation SSCCRussia Moscow

Sponsors (1)

Lead Sponsor Collaborator
State Scientific Centre of Coloproctology, Russian Federation

Country where clinical trial is conducted

Russian Federation, 

References & Publications (10)

Bobkiewicz A, Francuzik W, Krokowicz L, Studniarek A, Ledwosinski W, Paszkowski J, Drews M, Banasiewicz T. Botulinum Toxin Injection for Treatment of Chronic Anal Fissure: Is There Any Dose-Dependent Efficiency? A Meta-Analysis. World J Surg. 2016 Dec;40(12):3064-3072. doi: 10.1007/s00268-016-3693-9. Review. Erratum in: World J Surg. 2016 Dec;40(12 ):3063. — View Citation

Chen HL, Woo XB, Wang HS, Lin YJ, Luo HX, Chen YH, Chen CQ, Peng JS. Botulinum toxin injection versus lateral internal sphincterotomy for chronic anal fissure: a meta-analysis of randomized control trials. Tech Coloproctol. 2014 Aug;18(8):693-8. doi: 10.1007/s10151-014-1121-4. Epub 2014 Feb 6. Review. — View Citation

Delechenaut P, Leroi AM, Weber J, Touchais JY, Czernichow P, Denis P. Relationship between clinical symptoms of anal incontinence and the results of anorectal manometry. Dis Colon Rectum. 1992 Sep;35(9):847-9. — View Citation

Gui D, Cassetta E, Anastasio G, Bentivoglio AR, Maria G, Albanese A. Botulinum toxin for chronic anal fissure. Lancet. 1994 Oct 22;344(8930):1127-8. — View Citation

Jorge JM, Wexner SD. Anorectal manometry: techniques and clinical applications. South Med J. 1993 Aug;86(8):924-31. — View Citation

Jorge JM, Wexner SD. Etiology and management of fecal incontinence. Dis Colon Rectum. 1993 Jan;36(1):77-97. Review. — View Citation

Nelson RL, Thomas K, Morgan J, Jones A. Non surgical therapy for anal fissure. Cochrane Database Syst Rev. 2012 Feb 15;(2):CD003431. doi: 10.1002/14651858.CD003431.pub3. Review. — View Citation

Stewart DB Sr, Gaertner W, Glasgow S, Migaly J, Feingold D, Steele SR. Clinical Practice Guideline for the Management of Anal Fissures. Dis Colon Rectum. 2017 Jan;60(1):7-14. — View Citation

Valizadeh N, Jalaly NY, Hassanzadeh M, Kamani F, Dadvar Z, Azizi S, Salehimarzijarani B. Botulinum toxin injection versus lateral internal sphincterotomy for the treatment of chronic anal fissure: randomized prospective controlled trial. Langenbecks Arch Surg. 2012 Oct;397(7):1093-8. doi: 10.1007/s00423-012-0948-2. Epub 2012 Mar 20. — View Citation

Zetterström J, Mellgren A, Jensen LL, Wong WD, Kim DG, Lowry AC, Madoff RD, Congilosi SM. Effect of delivery on anal sphincter morphology and function. Dis Colon Rectum. 1999 Oct;42(10):1253-60. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Anal sphincter insufficiency Frequency of anal sphincter insufficiency according to the Wexner scale Up to 60 days
Secondary 2-item pain intensity (P2) Self reported pain intensity after the defecation and during the day after the surgical intervention. Each item is scored 0-10 (0 = no pain; 10 = pain as bad, as can can be). On day 7, 30 and 60
Secondary Non-Healing Wound Frequency of post-operative wound epithelialization On day 15, 30, 45, 60
Secondary Profilometry /sphincterometry findings Internal sphincter spasm or local internal sphincter spasm by the data of anorectal profilometry / or anorectal sphincterometry On day 30, 60 and 365
Secondary Temporary disability Duration of temporary disability Up to 60 days
Secondary Relap Frequency of relapses Up to 60 days
See also
  Status Clinical Trial Phase
Completed NCT03554421 - Percutaneous Tibial Nerve Stimulation - an Alternative Treatment Option for Chronic Therapy Resistant Anal Fissure N/A
Terminated NCT02158013 - Treatment Of Chronic Anal Fissure N/A
Completed NCT01217515 - Diltiazem Hydrochloride Cream for Anal Fissure Phase 3
Recruiting NCT05117697 - Surgical Treatment of a Chronic Anal Fissure N/A
Completed NCT02527109 - The Effect of Intra-anal Nifedipine, Used As Add-on to Conservative Therapy, on Pain in Patients With Anal Fissure Phase 2/Phase 3
Recruiting NCT03920449 - Postero-lateral Internal Sphincterotomy vs Botulinum Toxin Injection in the Treatment of Chronic Anal Fissure N/A
Enrolling by invitation NCT04793347 - Effect of Shock Waves Therapy on Chronic Anal Fissure N/A
Completed NCT04166175 - High Dose Multiple Site Injection of Botox Versus Lateral Sphincterotomy in Chronic Analfissure N/A
Completed NCT02395809 - Transcutaneous Posterior Tibial Nerve Stimulation for Treatment of Chronic Anal Fissure N/A
Completed NCT01132391 - Perianal Versus Endoanal Application of Glyceryl Trinitrate 0.4% Ointment for Chronic Anal Fissure Phase 3
Completed NCT01500889 - Conventional Lateral Internal Sphincterotomy, V-Y Anoplasty and Tailored Lateral Internal Sphincterotomy With V-YF in Treatment of Chronic Anal Fissure(CAF) N/A
Completed NCT03872765 - Outcomes of the Use of CO2 (Carbon Dioxide) Laser in the Treatment of Chronic Anal Fissure N/A
Completed NCT00972907 - An Open Label Study to Examine the Effect of Coated Nifedipine Suppository on Anal Fissure Pain and Healing in Human Subjects Phase 1/Phase 2